Nuformix (LON:NFX) Sets New 52-Week Low at $0.18

Nuformix plc (LON:NFX)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 0.18 ($0.00) and last traded at GBX 0.18 ($0.00), with a volume of 1347616 shares trading hands. The stock had previously closed at GBX 0.21 ($0.00).

Nuformix Stock Down 12.0 %

The company has a 50-day simple moving average of GBX 0.22 and a 200-day simple moving average of GBX 0.28. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.51 and a quick ratio of 3.35. The firm has a market cap of £1.50 million, a PE ratio of -1.63 and a beta of 0.29.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.